Beijing Sun-Novo Pharmaceutical Research Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 323.82 million compared to CNY 223.41 million a year ago. Revenue was CNY 324.31 million compared to CNY 224.11 million a year ago.

Net income was CNY 87.38 million compared to CNY 58.97 million a year ago. Basic earnings per share from continuing operations was CNY 0.7786 compared to CNY 0.7 a year ago. Diluted earnings per share from continuing operations was CNY 0.7786 compared to CNY 0.7 a year ago.